Skip to content

EDIT EDITAS MEDICINE INC

Follow

COM (common), issuer CIK 1650664

Filings received so far for Q3 2026: 7 13F filers report a position in EDIT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Green Alpha Advisors, LLC24,303$62.5K0.04%-131,74313F-HRTimeline
DLK Investment Management, LLC16,619$42.7K0.02%-1,08313F-HRTimeline
Valeo Financial Advisors, LLC10,042$25.8K<0.01%013F-HRTimeline
GAMMA Investing LLC2,103$5.41K<0.01%+82113F-HRTimeline
MassMutual Private Wealth & Trust, FSB530$1.36K<0.01%013F-HRTimeline
Versant Capital Management, Inc100$257<0.01%013F-HRTimeline
Farther Finance Advisors, LLC76$195<0.01%-57713F-HRTimeline